1-9 of 9
virus diseases
Close
Sort by
Journal Articles

Autoimmune- and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination

Clinical Trials & Observations
Andrew Jay Portuguese, Cassandra Sunga, Rebecca Kruse-Jarres, Terry Gernsheimer, Janis Abkowitz
Journal: Blood Advances
Blood Adv (2021) 5 (13): 2794–2798.
https://doi.org/10.1182/bloodadvances.2021004957
Published: 2021
Journal Articles

Large-scale GMP-compliant CRISPR-Cas9–mediated deletion of the glucocorticoid receptor in multivirus-specific T cells

Rafet Basar, May Daher, Nadima Uprety, Elif Gokdemir, Abdullah Alsuliman, Emily Ensley, Gonca Ozcan, Mayela Mendt, Mayra Hernandez Sanabria, Lucila Nassif Kerbauy, Ana Karen Nunez Cortes, Li Li, Pinaki P. Banerjee, Luis Muniz-Feliciano, Sunil Acharya, Natalie W. Fowlkes, Junjun Lu, Sufang Li, Stephan Mielke, Mecit Kaplan, Vandana Nandivada, Mustafa Bdaiwi, Alexander D. Kontoyiannis, Ye Li, Enli Liu, Sonny Ang, David Marin, Lorenzo Brunetti, Michael C. Gundry, Rolf Turk, Mollie S. Schubert, Garrett R. Rettig, Matthew S. McNeill, Gavin Kurgan, Mark A. Behlke, Richard Champlin, Elizabeth J. Shpall, Katayoun Rezvani
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3357–3367.
https://doi.org/10.1182/bloodadvances.2020001977
Published: 2020
Includes: Supplemental data
Journal Articles

Promoting platelets is a therapeutic option to combat severe viral infection of the lung

Jiahuang Qiu, Juan Ma, Shuping Zhang, Jinxiang Han, Sijin Liu
Journal: Blood Advances
Blood Adv (2020) 4 (8): 1640–1642.
https://doi.org/10.1182/bloodadvances.2020001669
Published: 2020
Journal Articles

Late infectious complications in hematopoietic cell transplantation survivors: a population-based study

Aimee M. Foord, Kara L. Cushing-Haugen, Michael J. Boeckh, Paul A. Carpenter, Mary E. D. Flowers, Stephanie J. Lee, Wendy M. Leisenring, Beth A. Mueller, Joshua A. Hill, Eric J. Chow
Journal: Blood Advances
Blood Adv (2020) 4 (7): 1232–1241.
https://doi.org/10.1182/bloodadvances.2020001470
Published: 2020
Includes: Supplemental data
Journal Articles

Impact of γδ T cells on clinical outcome of hematopoietic stem cell transplantation: systematic review and meta-analysis

Lucas C. M. Arruda, Ahmed Gaballa, Michael Uhlin
Journal: Blood Advances
Blood Adv (2019) 3 (21): 3436–3448.
https://doi.org/10.1182/bloodadvances.2019000682
Published: 2019
Includes: Supplemental data
Journal Articles

Increased overall and bacterial infections following myeloablative allogeneic HCT for patients with AML in CR1

Clinical Trials & Observations
Celalettin Ustun, Soyoung Kim, Min Chen, Amer M. Beitinjaneh, Valerie I. Brown, Parastoo B. Dahi, Andrew Daly, Miguel Angel Diaz, Cesar O. Freytes, Siddhartha Ganguly, Shahrukh Hashmi, Gerhard C. Hildebrandt, Hillard M. Lazarus, Taiga Nishihori, Richard F. Olsson, Kristin M. Page, Genovefa Papanicolaou, Ayman Saad, Sachiko Seo, Basem M. William, John R. Wingard, Baldeep Wirk, Jean A. Yared, Miguel-Angel Perales, Jeffery J. Auletta, Krishna V. Komanduri, Caroline A. Lindemans, Marcie L. Riches
Journal: Blood Advances
Blood Adv (2019) 3 (17): 2525–2536.
https://doi.org/10.1182/bloodadvances.2019000226
Published: 2019
Journal Articles

Safety and feasibility of virus-specific T cells derived from umbilical cord blood in cord blood transplant recipients

Clinical Trials & Observations
Allistair A. Abraham, Tami D. John, Michael D. Keller, C. Russell Y. Cruz, Baheyeldin Salem, Lauren Roesch, Hao Liu, Fahmida Hoq, Bambi J. Grilley, Adrian P. Gee, Hema Dave, David A. Jacobsohn, Robert A. Krance, Elizabeth. J. Shpall, Caridad A. Martinez, Patrick J. Hanley, Catherine M. Bollard
Journal: Blood Advances
Blood Adv (2019) 3 (14): 2057–2068.
https://doi.org/10.1182/bloodadvances.2019000201
Published: 2019
Includes: Supplemental data
Journal Articles

Delayed immune reconstitution after allogeneic transplantation increases the risks of mortality and chronic GVHD

Nelli Bejanyan, Claudio G. Brunstein, Qing Cao, Aleksandr Lazaryan, Xianghua Luo, Julie Curtsinger, Rohtesh S. Mehta, Erica Warlick, Sarah A. Cooley, Bruce R. Blazar, Jeffrey S. Miller, Daniel Weisdorf, John E. Wagner, Michael R. Verneris
Journal: Blood Advances
Blood Adv (2018) 2 (8): 909–922.
https://doi.org/10.1182/bloodadvances.2017014464
Published: 2018
Includes: Supplemental data
Journal Articles

Long-term control of recurrent or refractory viral infections after allogeneic HSCT with third-party virus-specific T cells

Clinical Trials & Observations
Barbara Withers, Emily Blyth, Leighton E. Clancy, Agnes Yong, Chris Fraser, Jane Burgess, Renee Simms, Rebecca Brown, David Kliman, Ming-Celine Dubosq, David Bishop, Gaurav Sutrave, Chun Kei Kris Ma, Peter J. Shaw, Kenneth P. Micklethwaite, David J. Gottlieb
Journal: Blood Advances
Blood Adv (2017) 1 (24): 2193–2205.
https://doi.org/10.1182/bloodadvances.2017010223
Published: 2017
Includes: Supplemental data